XML 52 R36.htm IDEA: XBRL DOCUMENT v3.21.2
Goodwill and Other Intangible Assets (Tables)
12 Months Ended
Jun. 30, 2021
Goodwill and Other Intangible Assets  
Schedule of change in carrying amount of goodwill

    

Aytu BioPharma

    

Aytu Consumer Health

    

Consolidated

(In thousands)

Balance as of June 30, 2019

$

$

$

Goodwill acquired

 

19,453

 

8,637

 

28,090

Balance as of June 30, 2020

19,453

8,637

28,090

Goodwill acquired

 

37,712

 

 

37,712

Balance as of June 30, 2021

$

57,165

$

8,637

$

65,802

Schedule of finite lived intangible assets

June 30, 2021

Weighted-

Average

Gross

Remaining

Carrying

Accumulated

Net Carrying

Life (in

    

Amount

    

Amortization

    

Amount

    

years)

(In thousands)

Licensed asset

$

3,246

$

(1,430)

$

1,816

3.92

Acquired product technology right

 

45,400

 

(4,160)

 

41,240

 

12.88

Acquired technology right

30,200

(501)

29,699

16.75

Acquired product distribution rights

 

11,354

 

(2,073)

 

9,281

 

8.57

Acquired in-process R&D

2,600

2,600

Indefinite-lived

Acquired commercial technology

630

(178)

452

0.75

Acquired trade name

400

(56)

344

1.75

Acquired customer lists

 

390

 

(358)

 

32

 

0.01

Total

$

94,220

$

(8,756)

$

85,464

 

13.47

June 30, 2020

Weighted-

Average

Gross

Remaining

Carrying

Accumulated

    

Net Carrying

Life (in

    

Amount

    

Amortization

    

Impairment

    

Amount

    

years)

(In thousands)

Licensed assets

$

23,649

$

(7,062)

$

$

16,587

11.88

MiOXSYS Patent

 

380

 

(185)

 

(195)

 

Acquired product technology right

22,700

(1,513)

21,187

9.34

Acquired product distribution rights

11,354

(565)

10,789

7.78

Acquired customer lists

390

(98)

292

1.12

Total

$

58,473

$

(9,423)

$

(195)

$

48,855

9.11

Schedule of Indefinite lived intangible assets

June 30, 2021

Weighted-

Average

Gross

Remaining

Carrying

Accumulated

Net Carrying

Life (in

    

Amount

    

Amortization

    

Amount

    

years)

(In thousands)

Licensed asset

$

3,246

$

(1,430)

$

1,816

3.92

Acquired product technology right

 

45,400

 

(4,160)

 

41,240

 

12.88

Acquired technology right

30,200

(501)

29,699

16.75

Acquired product distribution rights

 

11,354

 

(2,073)

 

9,281

 

8.57

Acquired in-process R&D

2,600

2,600

Indefinite-lived

Acquired commercial technology

630

(178)

452

0.75

Acquired trade name

400

(56)

344

1.75

Acquired customer lists

 

390

 

(358)

 

32

 

0.01

Total

$

94,220

$

(8,756)

$

85,464

 

13.47

June 30, 2020

Weighted-

Average

Gross

Remaining

Carrying

Accumulated

    

Net Carrying

Life (in

    

Amount

    

Amortization

    

Impairment

    

Amount

    

years)

(In thousands)

Licensed assets

$

23,649

$

(7,062)

$

$

16,587

11.88

MiOXSYS Patent

 

380

 

(185)

 

(195)

 

Acquired product technology right

22,700

(1,513)

21,187

9.34

Acquired product distribution rights

11,354

(565)

10,789

7.78

Acquired customer lists

390

(98)

292

1.12

Total

$

58,473

$

(9,423)

$

(195)

$

48,855

9.11

Schedule of future amortization expense

     

June 30, 

(In thousands)

2022

$

8,038

2023

7,489

2024

7,333

2025

7,099

2026

6,331

Thereafter

46,574

Total future amortization expense

$

82,864